Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Envirotainer launches the Releye® RLP - simpler than passive, even better than active 2021-05-06 02:20
Carmine Therapeutics appoints Don Haut as CEO 2021-05-05 21:00
Yangtze River Pharmaceutical Group Selects TraceLink Platform for Global Compliance 2021-05-05 20:00
CSafe Global Providing Thermal Protection for COVID-19 Vaccine Shipments from BioNTech Facility 2021-05-05 20:00
Clarity receives US FDA clearance of IND Application for its next-generation PSMA theranostic products 2021-05-04 21:08
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study 2021-05-03 20:30
BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction 2021-05-03 20:00
Jacobio Announces FDA Approves IND Application to Develop KRAS G12C Inhibitor 2021-05-03 09:30
Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer is Expected to Alleviate the Oxygen Shortage Crisis during COVID-19 Pandemic 2021-05-01 17:17
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH(R) Diagnostic 2021-04-29 20:56
I-Mab Announces Upcoming Participation at May Conferences 2021-04-29 20:00
Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland 2021-04-29 13:04
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib) 2021-04-29 08:00
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration 2021-04-29 08:00
AnchorDx Jointly Publishes Clinical Research Paper: "Accurate Diagnosis of Pulmonary Nodules Using a Non-invasive DNA Methylation Test" 2021-04-28 21:00
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2 2021-04-28 20:00
CROs dMed and Clinipace Merge to Accelerate Customer Success 2021-04-28 20:00
I-Mab Filed 2020 Annual Report on Form 20-F 2021-04-28 20:00
Samsung Biologics Reports First Quarter 2021 Financial Results 2021-04-28 16:37
New Distribution Facility Expands Bushu Pharma's Gateway to Asia (GTA) Services 2021-04-28 14:00
1 246 247 248 249 250 412